Diclofenac may share CV risks of COX-2 inhibitors

摘要

Diclofenac seems to share the increased cardiovascular risks seen with selective cyclo-oxygenase-2 inhibitors,according to the authors of a systematic review,published online on 12 September (JAMA,http://jama.ama-assn.org).